Adams Diversified Equity Fund’s Bristol-Myers Squibb BMY Stock Holding History

Adams Diversified Equity Fund’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-270,300	Closed	-$17.1M	–	102
2021 Q1	$17.1M	Sell	270,300 -110,700	-29%	-$6.89M	0.73%	44
2020 Q4	$23.6M	Sell	381,000 -14,000	-4%	-$861K	1.07%	30
2020 Q3	$23.8M	Hold	395,000	–	–	1.16%	21
2020 Q2	$23.2M	Buy	395,000 +242,100	+158%	+$14.5M	1.23%	19
2020 Q1	$8.52M	Buy	+152,900	New	+$9.35M	0.54%	72

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Adams Diversified Equity Fund's BMY Position: Q2 2021 in Review

Adams Diversified Equity Fund sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 270,300 shares — an estimated $17.1M sold.

Adams Diversified Equity Fund first reported a position in BMY in Q1 2020 and held it in 5 quarters. The position peaked at $23.8M in Q3 2020. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Adams Diversified Equity Fund reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Adams Diversified Equity Fund sold 270,300 Bristol-Myers Squibb shares in Q2 2021, an estimated $17.1M.
Adams Diversified Equity Fund first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 5 quarters.
Adams Diversified Equity Fund's Bristol-Myers Squibb position peaked at $23.8M in Q3 2020.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Adams Diversified Equity Fund's 13F filing for Q2 2021, filed 23 Jul 2021.